Associate Professor Eddy Kizana
Co-director, Centre for Heart Research and Cardiac Gene Therapy Group Leader, Westmead Institute for Medical Research
About the talk: There has been renewed interest in gene therapy driven by an exciting yet modest number of successful clinical applications for monogenic diseases. Although monogenic diseases are a logical target, cardiac arrhythmias represent a group of conditions amenable to gene therapy because of focal therapeutic targets (biological pacemakers, nodal conduction) or bystander effects on non-transduced cells due to electrical coupling. Setbacks in the use of gene therapy for cardiac disease have motivated efforts to develop vectors with enhanced tropism for the heart and more efficient delivery methods. In this presentation, developments in the cardiac gene therapy program at Westmead will be presented.
About the speaker: Associate Professor Kizana is a physician/scientist at the Westmead Health Precinct and faculty with Sydney Medical School. He is a cardiologist/electrophysiologist at Westmead Hospital and Co-director for Centre for Heart Research and Cardiac Gene Therapy Group Leader at the Westmead Institute for Medical Research. Associate Professor Kizana divides his time between caring for patients with heart rhythm disorders and developing novel gene therapy approaches for the same.